Texas Capital (TCBI) and Axxess, a global technology platform for healthcare at home, announced a product integration to enable faster payment reconciliation for home health and hospice providers. The integration between Texas Capital’s RevNow product and Axxess RCM optimizes the back-office payer reconciliation workflow using sophisticated automation that matches payments and remittances, eliminating the need for manually tracking payments. Texas Capital’s RevNow is a revenue cycle management product that helped process 115 million claims nationwide in 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCBI:
- Texas Capital price target lowered to $90 from $95 at Stephens
- Texas Capital price target lowered to $86 from $92 at Keefe Bruyette
- Texas Capital price target lowered to $75 from $84 at Hovde Group
- Texas Capital Bancshares Reports Strong Q1 2025 Results
- Texas Capital Bancshares Earnings Call Highlights Robust Growth